CD24 and urinary bladder cancer: Jason E Duex and colleagues have demonstrated that surCD24− cells in bladder cancer contain CD24 residues in the nucleoplasm, and that it is the nucleoplasmic CD24 (nucCD24) that is responsible for driving surCD24− growth and metastasis [16].